Approved cancer drug may reduce kidney damage linked to nail-patella syndrome

Medical Xpress - latest medical and health news stories · 1h ago

Researchers led by Dr. Ralph Witzgall, a professor at the Chair of Molecular and Cellular Anatomy at the University of Regensburg, have deciphered a key disease mechanism underlying the hereditary kidney disorder nail-patella syndrome and identified a potential therapeutic strategy. Their findings demonstrate that an already approved drug can significantly reduce disease-causing changes. The…

Read original article on Medical Xpress - latest medical and health news stories →

Approved cancer drug may reduce kidney damage linked to nail-patella syndrome

Related news